A PYMNTS Company

Life Science in The Crosshairs of China’s Public Antitrust Enforcement

BY | March 22, 2019

By Jet Deng & Ken Dai As a sector closely pertinent to people’s livelihood, the life science sector has always been, and will continue to be, a focus of China’s…

By Jet Deng & Ken Dai

As a sector closely pertinent to people’s livelihood, the life science sector has always been, and will continue to be, a focus of China’s antitrust enforcement. In 2018, China’s public antitrust enforcement entered into a transitional period due to the internal institutional reform, which will remodel China’s antitrust enforcement regime with a series of significant changes to take place. This article highlights the major changes brought by the institutional r

...
THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 3.238.174.191

Please verify email or join us to access premium content!